82 Further reduction of ribavirin dose in HCV genotype 2/3 patients receiving peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®): Interim results of a randomised controlled trial
Open Access
- 30 April 2006
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 44, S37-37
- https://doi.org/10.1016/s0168-8278(06)80083-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: